Journal of viral hepatitisHumansMaleHepatitis BChronicFemale
Impact of Non-Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha.
Chujing Li, Lihua Lin, Pei Zhou, Haiyi Cai, Songlian Liu, Xiaoyuan Chen, Aiqi Lu, Bo Li, Yaping Wang, Chuanghua Luo, Jianping Li, Yujuan Guan, Zhiwei Xie
Published: 202610.1111/jvh.70115
Abstract
Whether combining non-alcoholic fatty liver disease (NAFLD) affects the efficacy of pegylated interferon alpha (PEG-IFN-α) for patients with chronic hepatitis B (CHB) remains unknown; hence, we aimed to conduct a retrospective cohort study to investi…
Preview only. Read the full abstract at the source